“Global Genu Recurvatum Market to reach a market value of 8.72 Billion by 2031 growing at a CAGR of 5.3%”
The Global Genu Recurvatum Market size is expected to reach $8.72 billion by 2031, rising at a market growth of 5.3% CAGR during the forecast period.
The North America segment recorded 40% revenue share in the market in 2023. The region benefits from extensive insurance coverage, government healthcare support, and a growing elderly population prone to musculoskeletal issues. Additionally, the strong presence of leading orthopedic companies, sports medicine centers, and research institutions has accelerated the adoption of robotic-assisted surgeries, regenerative medicine, and AI-powered rehabilitation technologies.
One major driver is the rising number of sports-related injuries, particularly in high-impact activities such as basketball, football, and gymnastics. Athletes subject their knees to significant stress, increasing the likelihood of ligament damage and hyperextension. Additionally, traumatic knee injuries caused by accidents falls, and sudden impacts contribute to the growing cases, necessitating advanced orthopedic treatments, rehabilitation therapies, and custom knee braces to manage knee instability. Hence, this market is experiencing steady growth due to these factors.
Additionally, The world's population is aging at an unprecedented rate. In 2020, there were more people 60 years of age and older than children under five. Projections indicate that by 2050, the proportion of the world's population over 60 will nearly double, increasing from 12% to 22%. This demographic shift is particularly pronounced in low—and middle-income countries, expected to house two-thirds of the global elderly population by mid-century. Thus, the growing proportion of the aging population supports the market expansion.
However, The underlying biomechanical issues that affect the knees may not be recognized by many individuals, particularly those with modest to moderate symptoms. Instead, they may perceive hyperextension as a natural variation in their movement, failing to seek medical attention until the condition progresses. In developing regions with restricted access to specialized orthopedic care and physiotherapy, this dearth of awareness is particularly prevalent. Hence, these factors may hamper the growth of the market.
The COVID-19 pandemic significantly negatively impacted the genu recurvatum market, primarily due to disruptions in elective surgeries, delayed medical treatments, and reduced access to orthopedic care. As hospitals and healthcare centers focused on COVID-19 cases, many corrective surgeries, such as osteotomies and ligament reconstructions, were postponed or canceled, leaving patients without essential interventions. Furthermore, rehabilitation centers and physiotherapy clinics were compelled to close or operate at a reduced capacity, thereby restricting access to physical therapy and strength training, which are essential for non-surgical disease management. Hence, the pandemic had an overall negative factor on the market.
The leading players in the market are competing with diverse innovative offerings to remain competitive in the market. The above illustration shows the percentage of revenue shared by some of the leading companies in the market. The leading players of the market are adopting various strategies in order to cater demand coming from the different industries. The key developmental strategies in the market are Acquisitions, and Partnerships & Collaborations.
Based on end user, the market is segmented into hospitals, orthopedic clinics, and others. The orthopedic clinics segment acquired 33% revenue share in the market in 2023. These clinics are widely preferred for physical therapy, knee bracing, and gait correction programs, which are crucial for early-stage and moderate genu recurvatum cases. The shorter consultation times, cost-effective treatment options, and personalized rehabilitation programs make orthopedic clinics preferred over hospitals for many patients.
Based on treatment type, the market is bifurcated into surgical treatments and non-surgical treatments. The non-surgical treatments segment procured 43% revenue share in the market in 2023. The segment is primarily driven by the growing preference for conservative management approaches, as many patients and healthcare professionals prioritize physical therapy, knee braces, strength training, and orthotic supports over invasive procedures. The increasing availability of customized knee braces, AI-powered rehabilitation tools, and home-based physiotherapy programs has made non-surgical interventions more accessible and effective.
Free Valuable Insights: Global Genu Recurvatum Market size to reach USD 8.72 Billion by 2031
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Europe segment witnessed 31% revenue share in the market in 2023. Countries like Germany, France, and the United Kingdom have witnessed a surge in demand for personalized bracing solutions, physiotherapy services, and regenerative medicine approaches. Additionally, the region’s strong regulatory framework and government initiatives promoting healthcare accessibility have improved the availability of non-surgical knee treatments, sports rehabilitation centers, and specialized orthopedic clinics.
| Report Attribute | Details |
|---|---|
| Market size value in 2023 | USD 5.86 Billion |
| Market size forecast in 2031 | USD 8.72 Billion |
| Base Year | 2023 |
| Historical Period | 2020 to 2022 |
| Forecast Period | 2024 to 2031 |
| Revenue Growth Rate | CAGR of 5.3% from 2024 to 2031 |
| Number of Pages | 242 |
| Number of Tables | 429 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Market Share Analysis, Porter’s 5 Forces Analysis, Company Profiling, Companies Strategic Developments, SWOT Analysis, Winning Imperatives |
| Segments covered | Treatment Type, End User, Region |
| Country scope |
|
| Companies Included | Smith & Nephew plc, Stryker Corporation, 3M Company, Zimmer Biomet Holdings, Inc., Aspen Medical Products, LLC, THUASNE, Bauerfeind AG, Medi GmbH & Co. KG, and Tynor Orthotics Pvt. Ltd. |
By Treatment Type
By End User
By Geography
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 